Roche acquires diagnostics play CAPP Medical

Roche (SIX:ROG; OTCQX:RHHBY) acquired CAPP Medical (Palo Alto, Calif.), a genomics research company developing technology to detect and monitor circulating tumor DNA. Roche said the technology has the potential to aid in selecting cancer therapies and monitoring tumor progression. Financial terms were undisclosed. ...